Total Payments
$75,829
2024 Payments
$2,318
Companies
65
Transactions
746
Medicare Patients
7,917
Medicare Billing
$427,090
Payment Breakdown by Category
Other$36,000 (47.5%)
Food & Beverage$14,103 (18.6%)
Travel$12,382 (16.3%)
Consulting$9,609 (12.7%)
Education$3,735 (4.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $32,500 | 12 | 42.9% |
| Food and Beverage | $14,103 | 698 | 18.6% |
| Travel and Lodging | $12,382 | 26 | 16.3% |
| Consulting Fee | $9,609 | 5 | 12.7% |
| Education | $3,735 | 3 | 4.9% |
| Honoraria | $3,500 | 2 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Penumbra, Inc. | $21,248 | 13 | $0 (2021) |
| Bard Peripheral Vascular, Inc. | $18,838 | 13 | $0 (2022) |
| Medtronic Vascular, Inc. | $12,323 | 35 | $0 (2020) |
| Edwards Lifesciences Corporation | $7,184 | 92 | $0 (2024) |
| Toray International America Inc. | $4,618 | 3 | $0 (2017) |
| Boston Scientific Corporation | $1,499 | 18 | $0 (2024) |
| Baylis Medical Company Inc | $1,422 | 2 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $1,386 | 170 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $966.48 | 59 | $0 (2024) |
| Abbott Laboratories | $912.18 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,318 | 83 | Edwards Lifesciences Corporation ($507.30) |
| 2023 | $5,762 | 115 | Edwards Lifesciences Corporation ($3,831) |
| 2022 | $1,692 | 64 | Edwards Lifesciences Corporation ($468.28) |
| 2021 | $4,642 | 79 | Penumbra, Inc. ($2,400) |
| 2020 | $16,317 | 95 | Penumbra, Inc. ($12,430) |
| 2019 | $16,328 | 116 | BARD PERIPHERAL VASCULAR, INC. ($9,856) |
| 2018 | $20,903 | 113 | Medtronic Vascular, Inc. ($9,253) |
| 2017 | $7,866 | 81 | Toray International America Inc. ($4,618) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $96.55 | General |
| 11/25/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $96.55 | General |
| 11/22/2024 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $44.67 | General |
| 11/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $17.87 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $57.71 | General |
| Category: Vascular | ||||||
| 11/07/2024 | Medtronic, Inc. | HAWKONE (Device) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Directional Atherectomy Devices | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | GE HEALTHCARE | — | Food and Beverage | In-kind items and services | $154.30 | General |
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $4.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $8.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/13/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $18.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/31/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/28/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Cardiology | ||||||
| 08/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: CDS - Holter Monitoring_RM | ||||||
| 08/12/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/08/2024 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE MVP VVCS 6-12F (Device) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: DEVICES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,673 | 2,021 | $221,965 | $82,600 |
| 2022 | 25 | 1,708 | 2,098 | $210,314 | $77,529 |
| 2021 | 27 | 2,499 | 3,215 | $335,989 | $124,236 |
| 2020 | 32 | 2,037 | 2,447 | $374,839 | $142,726 |
Total Patients
7,917
Total Services
9,781
Medicare Billing
$427,090
Procedure Codes
112
All Medicare Procedures & Services
112 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92986 | Balloon dilation repair of aortic valve | Facility | 2023 | 13 | 14 | $35,364 | $13,609 | 38.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 255 | 266 | $36,176 | $13,295 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 101 | $24,543 | $8,899 | 36.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 69 | $13,524 | $6,114 | 45.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 63 | 64 | $16,576 | $6,087 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $13,917 | $4,979 | 35.8% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 26 | 26 | $14,742 | $4,560 | 30.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 68 | $9,316 | $4,055 | 43.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 295 | 486 | $7,776 | $2,642 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 40 | $6,880 | $2,530 | 36.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 35 | 37 | $7,104 | $2,314 | 32.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 37 | 37 | $5,550 | $2,124 | 38.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 147 | 179 | $4,833 | $1,783 | 36.9% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 51 | 51 | $3,876 | $1,388 | 35.8% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 17 | 17 | $3,570 | $1,362 | 38.1% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 20 | 33 | $2,475 | $1,211 | 48.9% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 132 | 137 | $3,288 | $1,177 | 35.8% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 38 | 40 | $2,640 | $1,004 | 38.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 66 | 77 | $2,477 | $719.96 | 29.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Facility | 2023 | 23 | 23 | $1,725 | $648.60 | 37.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 26 | 29 | $1,421 | $542.88 | 38.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 40 | 40 | $1,120 | $421.20 | 37.6% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 19 | 19 | $665.00 | $253.65 | 38.1% |
| 93922 | Ultrasound study of arm and leg arteries | Facility | 2023 | 26 | 27 | $648.00 | $248.13 | 38.3% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 14 | 15 | $630.00 | $241.95 | 38.4% |
About Dr. Nezar Falluji, MD
Dr. Nezar Falluji, MD is a Interventional Cardiology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053427872.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nezar Falluji, MD has received a total of $75,829 in payments from pharmaceutical and medical device companies, with $2,318 received in 2024. These payments were reported across 746 transactions from 65 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($32,500).
As a Medicare-enrolled provider, Falluji has provided services to 7,917 Medicare beneficiaries, totaling 9,781 services with total Medicare billing of $427,090. Data is available for 4 years (2020–2023), covering 112 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Phoenix, AZ
- Active Since 08/22/2006
- Last Updated 08/27/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1053427872
Products in Payments
- Indigo (Device) $18,848
- LUTONIX (Device) $18,647
- HawkOne (Device) $7,900
- Pressana (Device) $4,618
- TurboHawk (Device) $3,900
- PASCAL (Device) $3,404
- Indigo System (Device) $2,400
- XARELTO (Drug) $1,386
- GENERAL VASCULAR ACCESS (Device) $921.82
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) $805.51
- NRG (Device) $707.40
- ENTRESTO (Drug) $696.16
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $634.92
- IN.PACT Admiral (Device) $429.82
- ELIQUIS (Drug) $323.78
- LEQVIO (Drug) $270.32
- VYNDAQEL (Drug) $264.04
- MULTAQ (Drug) $254.30
- Repatha (Biological) $230.30
- Impella (Device) $210.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Phoenix
Paul Sorajja, M.d, M.D
Interventional Cardiology — Payments: $1.3M
Interventional Cardiology $1.3M
Dr. Nishant Gupta, M.d, M.D
Interventional Cardiology — Payments: $202,624
Interventional Cardiology $202,624
Dr. Suzanne Sorof, M.d, M.D
Interventional Cardiology — Payments: $78,637
Interventional Cardiology $78,637
Dr. Ahmad Jabri, Md, MD
Interventional Cardiology — Payments: $42,544
Interventional Cardiology $42,544
Dr. Vikram Prasad, M.d, M.D
Interventional Cardiology — Payments: $42,192
Interventional Cardiology $42,192
Dr. Rishi Patel, Md, MD
Interventional Cardiology — Payments: $24,738
Interventional Cardiology $24,738